Insulin Blood Test Explained: What It Measures and Why It's Ordered

This page is for educational purposes only and is not medical advice; consult a licensed physician about laboratory testing, results and any health decision. It summarises what the published literature describes about the insulin blood test. It does not interpret any individual result and does not provide reference ranges for self-assessment.

What Insulin Is and Where It Comes From

Insulin is a two-chain peptide hormone secreted by the beta cells of the pancreatic islets. It is synthesised first as preproinsulin, processed to proinsulin, and then cleaved into mature insulin plus an equimolar fragment called C-peptide. Both insulin and C-peptide enter the portal circulation together, but insulin is extracted substantially by the liver on first pass while C-peptide is not — which is why laboratories often measure the two analytes side by side when they want to distinguish endogenous secretion from administered insulin.

Because insulin regulates glucose uptake, hepatic glucose output, lipolysis and protein synthesis, its circulating concentration is not a fixed number. It rises after carbohydrate intake, falls during fasting, and varies with hepatic clearance, body composition and tissue sensitivity. Reviews of insulin sensitivity measurement have emphasised that a single insulin value is a snapshot of a dynamic feedback loop between glucose and the beta cell rather than a standalone property of the patient (PMID 16938587).

What the Test Actually Measures

Specimen and analyte

The test is performed on serum or plasma drawn by venepuncture. Most clinical laboratories quantify "immunoreactive insulin" — that is, whatever material in the sample binds the antibodies used by the assay. That phrasing matters, because immunoreactive insulin is not always identical to biologically active insulin.

Assay platforms

Historically insulin was measured by radioimmunoassay; modern laboratories predominantly use non-isotopic sandwich immunoassays on automated analysers, with mass spectrometry available in some reference settings. A comparability study of conventional immunoassay kits reported that insulin results differed measurably between commercial platforms, supporting the view that values are not freely interchangeable across laboratories or methods (PMID 35622611). The same theme appears in the insulin-sensitivity literature, where reviewers noted that the lack of a universally standardised insulin assay complicates comparison of calculated indices between studies and centres (PMID 16938587).

Derived indices rather than raw numbers

Much of the clinical and research literature does not use fasting insulin alone. Instead, insulin is combined with simultaneous glucose into surrogate indices of insulin sensitivity or resistance. A review of measures of insulin sensitivity described the hyperinsulinaemic–euglycaemic clamp as the reference technique and catalogued the simpler fasting-based and oral-glucose-based surrogates used when a clamp is impractical, noting that each surrogate carries its own assumptions and performance characteristics (PMID 16938587).

Why Clinicians Order an Insulin Test, as Described in the Literature

Evaluation of hypoglycaemia

The clearest clinical indication described in published reviews is the investigation of low blood glucose in a person who does not have diabetes. A review of hyperinsulinaemic hypoglycaemia in adults described the diagnostic approach as documenting inappropriately elevated insulin concentrations at the time of a low glucose, and discussed insulinoma and other causes of endogenous hyperinsulinism within that framework (PMID 15122101). A later clinical review of hypoglycaemia in patients without diabetes mellitus similarly placed paired glucose and insulin measurement at the centre of the work-up, alongside consideration of medication effects and other non-insulin causes (PMID 36300471).

In this setting the timing of the sample is the point: an insulin value drawn when glucose is normal answers a different question than one drawn during a documented hypoglycaemic episode. The reviews described supervised fasting protocols precisely because the diagnostic information lies in the pairing of the two analytes (PMID 15122101).

Research and characterisation of insulin resistance

Insulin measurement also underpins research into insulin resistance. In polycystic ovary syndrome, a biomarker review described insulin and insulin-resistance indices among the laboratory measures studied in that population alongside androgen and metabolic markers (PMID 28624501). A separate study of women with PCOS examined insulin resistance together with oxidative stress markers, reporting associations between the metabolic and oxidative measures assessed (PMID 30450993). These are research characterisations of groups, not thresholds for an individual.

Distinguishing endogenous from exogenous insulin

Because manufactured insulin does not contain C-peptide, laboratories commonly run C-peptide alongside insulin when the source of hyperinsulinaemia is in question. That pairing is described in the hypoglycaemia literature as part of separating endogenous hypersecretion from administered insulin or insulin secretagogues (PMID 15122101, PMID 36300471).

What Published Studies Associate With High Insulin Values

Elevated circulating insulin — hyperinsulinaemia — appears in the literature in two broad contexts: pathological hypersecretion, and compensatory elevation in the setting of reduced tissue sensitivity.

• Endogenous hypersecretion. The adult hyperinsulinaemic hypoglycaemia review described insulin-secreting tumours and other causes of inappropriate insulin secretion as presenting with hypoglycaemia accompanied by non-suppressed insulin (PMID 15122101).
• Compensatory hyperinsulinaemia. Reviews of insulin sensitivity measurement described elevated fasting insulin as a surrogate signal of reduced insulin action, the basis of fasting-ratio indices (PMID 16938587).
• Reproductive-endocrine research. Biomarker work in PCOS reported insulin-resistance measures among the markers evaluated in that condition (PMID 28624501), and a study of women with PCOS reported insulin resistance assessed together with oxidative markers (PMID 30450993).
• Comparative animal literature. Veterinary research has used insulin measurement as a metabolic phenotype marker: a study in horses reported an association between hyperinsulinaemia and raised ferritin, framed as possible dysmetabolic hyperferritinaemia (PMID 32042647), and a review of metabolic and endocrine insights in donkeys described insulin dysregulation among the endocrine parameters examined in that species (PMID 38396558). Animal findings do not transfer to human interpretation.

What Published Studies Associate With Low Insulin Values

Low or suppressed insulin is the expected physiological response to low glucose. The reviews of hypoglycaemia in adults described appropriately suppressed insulin during hypoglycaemia as pointing investigation away from hyperinsulinism and toward other mechanisms, including medication, critical illness and hormonal deficiency (PMID 36300471, PMID 15122101). Low insulin also accompanies beta-cell failure, where the clinical picture rather than the insulin number carries the diagnosis.

Assay and Interpretation Caveats: What Studies Report

Between-method variability

Researchers comparing conventional insulin immunoassay kits reported differences in measured values across platforms, which is why results are generally interpreted against the performing laboratory's own method and not transplanted between laboratories (PMID 35622611). Reviewers of insulin sensitivity measures made the same point about index comparability across studies (PMID 16938587).

Pre-analytical interference

Haemolysed samples are a recognised problem for insulin-family analytes. A study of haemolysis effects reported that haemolysis interfered with C-peptide immunoassay measurement, supporting careful specimen handling when insulin and C-peptide are run together (PMID 27231209). Erythrocyte-derived insulin-degrading activity is the mechanistic reason usually given for this class of interference.

Cross-reactivity and interfering antibodies

Immunoassays can respond to proinsulin and split products, and anti-insulin antibodies can distort measurement. The hyperinsulinaemic hypoglycaemia literature discussed insulin autoimmune phenomena among the differential considerations in adults with unexplained hyperinsulinaemia (PMID 15122101).

Binding proteins in related peptide assays

A broader methodological lesson comes from adjacent hormone assays. A review of free IGF-I measurement described how binding-protein biology complicates what an immunoassay actually reports for a peptide hormone and how free versus total fractions behave analytically (PMID 17429595). A review of pregnancy-associated plasma protein-A as an emerging cardiac biomarker likewise illustrated how a single analyte's clinical meaning depends on the assay format and population studied (PMID 17157395).

Summary table of reported caveats

What the Insulin Test Does Not Settle

A fasting insulin value does not by itself diagnose insulin resistance, predict an individual's future metabolic course, or establish a cause for symptoms. Reviewers of insulin sensitivity measurement positioned the clamp — not fasting insulin — as the reference method and described surrogates as approximations whose agreement with the clamp varies (PMID 16938587). In hypoglycaemia, the reviews made clear that the number is meaningful only in relation to simultaneous glucose and clinical circumstance (PMID 15122101).

Unrelated biochemistry findings can also travel alongside insulin in research datasets without implying causation; for example, a study measuring intracellular free magnesium in healthy horses characterised an analytical method in a normal population rather than establishing a clinical link to insulin status (PMID 29740897).

Anyone who has had an insulin test should discuss the result with the clinician who ordered it, since interpretation depends on the assay used, the fasting state, concurrent glucose and the clinical question being asked. Nothing here substitutes for that conversation.

References

• Measures of insulin sensitivity (Clinics in Laboratory Medicine, 2006)
• Hyperinsulinemic hypoglycemia in adults (Annales d'Endocrinologie, 2004)
• Hypoglycaemia in patients without diabetes mellitus (Nederlands Tijdschrift voor Geneeskunde, 2022)
• Measurement comparability of insulin assays using conventional immunoassay kits (Journal of Clinical Laboratory Analysis, 2022)
• Hemolysis Affects C-Peptide Immunoassay (Journal of Clinical Laboratory Analysis, 2016)
• New biomarkers for diagnosis and management of polycystic ovary syndrome (Clinica Chimica Acta, 2017)
• Insulin resistance and oxidative marker in women with PCOS (Archives of Physiology and Biochemistry, 2020)
• Utility of free IGF-I measurements (Pituitary, 2007)
• Pregnancy-associated plasma protein-A: an emerging cardiac biomarker (International Journal of Cardiology, 2007)
• Possible dysmetabolic hyperferritinemia in hyperinsulinemic horses (Open Veterinary Journal, 2020)
• Metabolic and Endocrine Insights in Donkeys (Animals, 2024)
• Intracellular free magnesium concentration in healthy horses (Journal of Animal Physiology and Animal Nutrition, 2018)